Glanbia (GL9) CMD 2025 summary

Strategic direction and growth ambitions

• Focus on high-growth, high-margin segments in performance nutrition, health & nutrition, and dairy nutrition, leveraging consumer megatrends like protein demand, functional benefits, and clean-label preferences.

• Five key growth drivers: global expansion of ON and lifestyle brands, scaling healthy nutrition, optimizing dairy nutrition, international expansion, and innovation investment.

• Ambition to grow performance nutrition to $2B+ and healthy nutrition to $1B, with significant investments in M&A and CapEx to support global capacity and innovation.

• Transformation program aims for $60M+ in annual savings by 2027, with at least 50% reinvested for growth, focusing on operational efficiency, digital transformation, and portfolio optimization.

• Portfolio optimization through divestitures (SlimFast, Body & Fit) and acquisitions (Flavor Producers, Colostrum Bioactives, Sweetmix, Sycor/Scicore).

Financial guidance and targets

• Targeting 5%-7% annual organic revenue growth in performance nutrition, 4%-6% in health & nutrition, with EPS growth of 7%-11% and 85%+ cash conversion.

• Performance nutrition EBITDA margin targeted to expand by up to 250 bps from 2025 base, with margin progression supported by transformation savings and portfolio optimization.

• Health & nutrition aims for 17%-19% EBITDA margin, with growth driven by organic expansion and acquisitions.

• Dairy nutrition to deliver $150-$160M annual EBITDA, focusing on cash returns and operational efficiency.

• Over $1.5B in operating cash flow targeted for the next three years, supporting investments, dividends, and buybacks, with dividend payout ratio raised to 30%-40%.

Business developments and innovation

• Recent acquisitions include Flavor Producers, Sweet Mix, Colostrum Bioactives, and Sycor/Scicore, expanding global manufacturing and innovation capabilities.

• Optimum Nutrition remains the flagship brand, with strong global growth, digital engagement, and innovation in formats and flavors.

• Isopure repositioned to target female and lifestyle consumers, leveraging clean label and intentionality trends, with double investment since 2022.

• Health & Nutrition division established, focusing on premix solutions and natural/organic flavors, with global reach and strong R&D pipeline.

• Innovation elevated as a group-wide growth pillar, with over 230 scientists and a new Chief Science Officer driving science and product development.